These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 3026615)

  • 1. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex antigens in v-Ki-ras transformed cells: the different antigens are expressed and induced by interferons independently of one another and of the anti-viral state.
    Morris AG
    Immunology; 1990 Oct; 71(2):224-9. PubMed ID: 1699881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells.
    Wan YJ; Orrison BM; Lieberman R; Lazarovici P; Ozato K
    J Cell Physiol; 1987 Feb; 130(2):276-83. PubMed ID: 3102507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA; Walsh J; Andrews PW
    Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha.
    Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M
    Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
    Kelley VE; Fiers W; Strom TB
    J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
    Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
    Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability.
    Takiguchi M; Ting JP; Buessow SC; Boyer C; Gillespie Y; Frelinger JA
    Eur J Immunol; 1985 Aug; 15(8):809-14. PubMed ID: 2411569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines.
    Klyczek KK; Murasko DM; Blank KJ
    J Immunol; 1987 Oct; 139(8):2641-8. PubMed ID: 3116091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines.
    Rinke de Wit TF; Vloemans S; van den Elsen PJ; Haworth A; Stern PL
    J Immunol; 1990 Feb; 144(3):1080-7. PubMed ID: 2104910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.
    Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H
    Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.